Applicant, as named in the Orange Book

Astrazeneca

AstraZeneca PLC · NYSE: AZN

Company and ticker: cliffwatch mapping, checked against SEC EDGAR · SEC filings

Next listed expiry: Airsupra on 28 May 2030. 13 products with live protection, 10 without.

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis
Airsupra NDA 214070 albuterol sulfate; budesonide	albuterol sulfate; budesonide	28 May 2030 patent, carve-out possible	patent, carve-out possible
Symbicort Aerosphere NDA 216579 · 2 strengths budesonide; formoterol fumarate	budesonide; formoterol fumarate	28 May 2030 patent	patent
Bevespi Aerosphere NDA 208294 formoterol fumarate; glycopyrrolate	formoterol fumarate; glycopyrrolate	17 Mar 2031 patent, carve-out possible	patent, carve-out possible
Koselugo NDA 219943 · 2 strengths selumetinib sulfate	selumetinib sulfate	19 Nov 2032 exclusivity	exclusivity
Koselugo NDA 213756 · 2 strengths selumetinib sulfate	selumetinib sulfate	19 Nov 2032 exclusivity	exclusivity
Truqap NDA 218197 · 2 strengths capivasertib	capivasertib	16 Apr 2033 patent	patent
Lokelma NDA 207078 · 2 strengths sodium zirconium cyclosilicate	sodium zirconium cyclosilicate	14 Oct 2035 patent	patent
Calquence NDA 216387 acalabrutinib maleate	acalabrutinib maleate	1 Jul 2036 patent	patent
Calquence NDA 210259 acalabrutinib	acalabrutinib	1 Jul 2036 patent	patent
Brilinta NDA 022433 · 2 strengths ticagrelor	ticagrelor	27 Jul 2036 patent	patent
Etcamah NDA 220359 camizestrant	camizestrant	22 Oct 2041 patent	patent
Lynparza NDA 208558 · 2 strengths olaparib	olaparib	25 Oct 2041 patent, carve-out possible	patent, carve-out possible
Tagrisso NDA 208065 · 2 strengths osimertinib mesylate	osimertinib mesylate	26 Nov 2042 patent, carve-out possible	patent, carve-out possible

Recent events

Nexium · Generic approved · ANDA 218687, Novitium PharmaApproved 25 Sep 2026Detected 25 Oct 2026
Brilinta · Generic approved · ANDA 217679, Mankind PharmaApproved 6 Feb 2026Detected 25 Oct 2026
Brilinta · Generic approved · ANDA 219006, Zhejiang JingxinApproved 24 Mar 2026Detected 25 Oct 2026
Brilinta · Generic approved · ANDA 218962, Sciegen PharmsApproved 28 Oct 2025Detected 25 Oct 2026
Brilinta · Generic approved · ANDA 208596, MsnApproved 28 Oct 2025Detected 25 Oct 2026
Brilinta · Generic approved · ANDA 208584, ApotexApproved 28 Oct 2025Detected 25 Oct 2026
Brilinta · Generic approved · ANDA 208576, AlembicApproved 28 Oct 2025Detected 25 Oct 2026
Brilinta · Generic approved · ANDA 218869, PharmobedientApproved 20 Aug 2026Detected 25 Oct 2026
Brilinta · Generic approved · ANDA 208541, Dr ReddysApproved 28 Oct 2025Detected 25 Oct 2026
Lokelma · First generic approved · ANDA 217549, LupinApproved 7 Aug 2026Detected 25 Oct 2026
Lokelma · Generic approved · ANDA 217549, LupinApproved 7 Aug 2026Detected 25 Oct 2026
Brilinta · Generic approved · ANDA 208539, Micro LabsApproved 27 Apr 2026Detected 25 Oct 2026
Brilinta · Generic approved · ANDA 208537, Invagen PharmsApproved 28 Oct 2025Detected 25 Oct 2026
Brilinta · Generic approved · ANDA 208508, SunshineApproved 28 Oct 2025Detected 25 Oct 2026
Brilinta · Generic approved · ANDA 210219, Alkem Labs LtdApproved 28 Oct 2025Detected 25 Oct 2026
Brilinta · Generic approved · ANDA 212258, Macleods PharmsApproved 28 Oct 2025Detected 25 Oct 2026
Brilinta · Generic approved · ANDA 216187, Changzhou PharmApproved 28 Oct 2025Detected 25 Oct 2026
Symbicort · Generic approved · ANDA 212212, Teva Pharms Usa IncApproved 23 Apr 2026Detected 25 Oct 2026
Nexium · Generic approved · ANDA 218687, Novitium PharmaApproved 25 Sep 2026Detected 25 Oct 2026
Brilinta · Generic approved · ANDA 211498, TaroApproved 28 Oct 2025Detected 25 Oct 2026
Lynparza · Exclusivity expires within 90 days ODE-283Exclusivity expires 27 Dec 2026Detected 24 Oct 2026
Lynparza · Exclusivity expires within 90 days ODE-283Exclusivity expires 27 Dec 2026Detected 24 Oct 2026
Calquence · Exclusivity expires within 90 days ODE-274Exclusivity expires 21 Nov 2026Detected 24 Oct 2026

Products without listed protection (10)

Drug	Ingredient	Earliest generic entry	Basis
Crestor NDA 021366 · 4 strengths rosuvastatin calcium	rosuvastatin calcium	open now no listed protection	no listed protection
Daliresp NDA 022522 · 2 strengths roflumilast	roflumilast	open now no listed protection	no listed protection
Faslodex NDA 021344 fulvestrant	fulvestrant	open now no listed protection	no listed protection
Iressa NDA 206995 gefitinib	gefitinib	open now no listed protection	no listed protection
Nexium NDA 021153 · 2 strengths esomeprazole magnesium	esomeprazole magnesium	open now no listed protection	no listed protection
Nexium NDA 021957 · 4 strengths esomeprazole magnesium	esomeprazole magnesium	open now no listed protection	no listed protection
Nexium NDA 022101 esomeprazole magnesium	esomeprazole magnesium	open now no listed protection	no listed protection
Prilosec Otc NDA 021229 omeprazole magnesium	omeprazole magnesium	open now no listed protection	no listed protection
Pulmicort Respules NDA 020929 · 3 strengths budesonide	budesonide	open now no listed protection	no listed protection
Symbicort NDA 021929 · 2 strengths budesonide; formoterol fumarate dihydrate	budesonide; formoterol fumarate dihydrate	open now no listed protection	no listed protection